Jared Hall is currently a Pharmaceutical Analyst at Nanopharm Ltd, an Aptar Pharma Company (UK) in the New Modalities Pharmaceutical Development Department.
He is currently studying Chemistry as a Bachelor’s degree at University of South Wales (UK), working on a research project on the effect of physicochemical properties on dry powder inhalers performance employing Nanopharm’s SmartTrack™ tools.
He joined Nanopharm in 2018 working as a laboratory technician before moving to the role of pharmaceutical analyst while carrying out his degree under a USW Network 75 scheme. During these five years, he acquired useful knowledge and expertise in the research and development of respiratory and nasal drug products. His main area of work involved pressurized metered dose inhalers, dry powder inhalers and nasal spray: from formulation development to in vitro characterization and data analysis.
He has presented his work in a couple of conferences: Drug Delivery to the Lungs 2021 and Respiratory Drug Delivery 2022.